Cite
MLA Citation
David Bakhshinyan et al.. “EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA.” Neuro-oncology, vol. 23, n.d., p. i10. http://access.bl.uk/ark:/81055/vdc_100130765509.0x000035